Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Download
  • Rewards
  • Help
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
    • Esop
  • About
    • About us
    • Newsroom
    • Awards
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Monte Rosa Therapeutics

14.32
+0.06000.42%
Post-market: 14.530.2100+1.47%17:08 EDT
Volume:1.06M
Turnover:15.10M
Market Cap:1.22B
PE:-8.21
High:14.34
Open:14.21
Low:13.83
Close:14.26
52wk High:25.77
52wk Low:4.80
Shares:85.31M
Float Shares:54.48M
Volume Ratio:0.99
T/O Rate:1.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7450
EPS(LYR):-0.4650
ROE:-42.66%
ROA:-21.63%
PB:2.51
PE(LYR):-30.80

Loading ...

OverviewCompanyNewsFilings

Monte Rosa Therapeutics Announces Clinical Supply Agreement To Support Phase 2 Trial Evaluating Mrt-2359 In Combination With Apalutamide For The Treatment Of Metastatic Castration-Resistant Pros

Reuters
·
Mar 16

BUZZ-U.S. STOCKS ON THE MOVE-Sable Offshore, Nebius, Upstart

Reuters
·
Mar 16

BUZZ-Monte Rosa rises on lining up new combo trial in advanced prostate cancer

Reuters
·
Mar 16

Monte Rosa to launch Phase 2 trial of MRT-2359 plus apalutamide in AR-mutant mCRPC in Q3 2026

Reuters
·
Mar 16

Monte Rosa Therapeutics Inc - to Conduct and Sponsor Trial; Johnson & Johnson to Supply Erleada

THOMSON REUTERS
·
Mar 16

Monte Rosa Therapeutics Inc - to Initiate Phase 2 Study of Mrt-2359 With Apalutamide in Q3 2026

THOMSON REUTERS
·
Mar 16

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 06, 2026 Pre-MKt
Financial Report Announcement
May 07, 2026 Pre-MKt
Financial Report Announcement
Mar 17, 2026 Pre-MKt
Financial Report Announcement
Nov 06, 2025 Pre-MKt
Financial Report Announcement
Aug 07, 2025 Pre-MKt

Dividend History

no data

No relevant data is available

Valuation Analysis

-8.21
Current
2.44
Sector Average
21.51%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-8.21
Maximum
91.05
+1 STD
25.01
Minimum
-41.78
-1 STD
-20.13
Average
2.44

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.